---
title: "Moxetumomab pasudotox"
slug: "moxetumomab-pasudotox"
date: "2023-11-20"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[Antibody Drug Conjugates]]

# Moxetumomab pasudotox

- Mechanism: CD22-directed antibody-drug fused to Pseudomonas exotoxin (PE38) which is internalized & causes inhibition of protein synthesis & apoptotic cell death
- Approved indication: Hairy cell leukemia
- Dosing: 0.04 mg/kg on d 1, 3, 5 of 28-d cycle administered w/ 1 L isotonic IV before & after + H1 & H2 antagonists before + oral corticosteroid after infusion; consider low-dose aspirin on d 1-8 of each cycle; delay infusion for â‰¥grade 2-3 SCr; grade 2 capillary leak syndrome delay tx, grade 3-4 discontinue; discontinue for hemolytic uremic syndrome
- PK/PD: T1/2 1.4 h
- AEs: Capillary leak syndrome, infusion rxns, hemolytic uremic syndrome, â†“ albumin, â†“ Ca, â†“ Phos, â†‘ LFTs
- DDI: N/A
